Pierre Kyme - 05 Feb 2025 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Chief Business Officer
Signature
/s/ Pierre Kyme
Issuer symbol
ARMP
Transactions as of
05 Feb 2025
Transactions value $
$0
Form type
4
Filing time
07 Feb 2025, 16:19:28 UTC
Previous filing
25 Apr 2025
Next filing
25 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Options (Right to Buy) Award $0 +100K $0.00 100K 05 Feb 2025 Common Stock 100K $2.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the Stock Options shall vest on February 5th of each of 2026, 2027, 2028 and 2029, in each case subject to continuous service through the applicable vesting date.